deltatrials
Completed NA NCT00247000

A Strategy of Home Telehealth for Management of Congestive Heart Failure(STARTEL)

A Strategy of Home Telehealth for Management of Congestive Heart Failure: STARTEL

Sponsor: AstraZeneca

Conditions Heart Failure
Interventions Routine Care in a HF clinic vs Home Telehealth Care for HF
Updated 6 times since 2017 Last updated: Oct 26, 2022 Started: Nov 30, 2007 Primary completion: Oct 31, 2009 Completion: Oct 31, 2012

A NA clinical study on Heart Failure, this trial is completed. The trial is conducted by AstraZeneca and has accumulated 6 data snapshots since 2007. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Nov 2022 — Jul 2024 [monthly]

    Completed NA

    Status: Unknown Status → Completed · Phase: PHASE4 → NA

  4. Jan 2021 — Nov 2022 [monthly]

    Unknown Status PHASE4

  5. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE4

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE4

    First recorded

Nov 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AstraZeneca
  • Atlantic Health Sciences Corporation
  • Canada Health Infoway
  • Continuing Care Nova Scotia
  • Heart and Stroke Foundation of Canada
  • Nova Scotia Health Authority
  • Nova Scotia Telehealth Program
Data source: Nova Scotia Health Authority

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Saint John, Canada